Live prices from 3 UK suppliers, from £39.95, compared side by side so you never overpay.
Copy the code — you'll paste it at checkout.
with our exclusive code
You're about to visit an external supplier
with our exclusive code
By clicking "Continue", you acknowledge that you understand and accept the above. Read our full disclosure.
Crystagen
Compare 3 prices for Crystagen. Cheapest: £39.95. Average: £46.65.
| Compare | Visit | |||||||
|---|---|---|---|---|---|---|---|---|
| £54.99 | £2.75/mg | In Stock | Free |
Lab Tested
|
— | |||
| £45.00 | £2.25/mg | In Stock | Free over £200 |
Lab Tested
|
— |
More ways to compare Crystagen
Different views of the same live UK pricing, tuned for how you like to shop.
Compare another peptide
All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.
We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.
By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.
EDP Tripeptide | Thymus Immune Bioregulator
Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it enhances immune function by stimulating normal lymphocyte proliferation while inhibiting tumor cell growth. Research shows effectiveness in normalizing immunity in 82% of elderly patients (vs 56% control) and reducing respiratory infections in athletes by doubling HSP gene expression.
Crystagen works through epigenetic regulation by influencing gene expression and protein synthesis in immune cells. It regulates the synthesis of heat-shock proteins, cytokines, and affects cell differentiation, proliferation, and apoptosis. The EDP peptide enhances spontaneous proliferative activity of normal lymphocytes while inhibiting proliferation of tumor cells (K-562 erythromyelosis). It activates B-cell immune system and thymic epithelial cells (VTEC2.H/S).
EDP
Glutamic Acid
Position 1
Aspartic Acid
Position 2
Proline
Position 3
Normalizes immunogram in elderly patients with impaired immunity.
Restores immune function after infectious diseases.
Helps normalize immunity after radiation and chemotherapy exposure.
Increases stress resistance and reduces respiratory infections in athletes.
Doubles expression of heat-shock protein gene HSPA1A.
Inhibits proliferation of K-562 human erythromyelosis tumor cells.
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
| Athletic support | 10-20 mg | Daily during training cycles | Oral capsules |
Injectable form available for direct administration.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Research protocol | 10 mg | Daily for 10 days | IM or SubQ |
Both have immunoprotecting properties; different mechanisms complement each other.
Crystagen (EDP) is derived from thymalin; complementary immune effects.
Often combined in comprehensive anti-aging Khavinson protocols.
Related immune peptides; can be used together.
Immune activation and gene expression modulation begins
Effects persist due to epigenetic changes
Measurable immune function improvements
Cumulative benefits with periodic cycles
PMC/NCBI
EDP (crystagen) identified in thymalin; regulates gene expression, HSP synthesis, cytokines, and cell differentiation.
Advances in Gerontology
Crystagen normalized immunogram in 82% of patients vs 56% in control group.
Bulletin of Experimental Biology and Medicine
Crystagen doubled HSP gene expression, normalized IL-6, and reduced respiratory infections in athletes.
Cell Technologies in Biology and Medicine
EDP enhances normal lymphocyte proliferation while inhibiting K-562 tumor cell proliferation.
Be the first to know when prices drop on your favourite peptides
No spam. Unsubscribe anytime. We respect your privacy.